ISSN: 1859 - 2872
Evaluation of some immunohistochemical characteristics in papillary urothelial carcinoma at the 108 Military Central Hospital
Main Article Content
Keywords
Abstract
Objective: To evaluate some characteristics of age, genders, to determine expression of immunohistochemical markers CK20, P53, Ki67 and the expression of immunohistochemistry markers in papillary urothelial carcinoma at 108 Military Central Hospital. Subject and method: A descriptive study on 51 operated patients with papillary urothelial carcinoma diagnosed at 108 Military Central Hospital from January 2019 to January 2021. All samples were immunohistochemically stained with 3 makers CK20, P53, Ki67. Result and conclusion: The mean age of papillary urothelial carcinoma patients was 62.73 ± 11.16; 90.2% male. The rates of local positive and diffuse positive with CK20 were 51%, 31.4%, respectively. The strong and weak positive cases of P53 were 45.1%, 33.3%, respectively. The low expression cases with Ki67 were 70.6%.
Article Details
References
2. Trịnh Tiên Phong, Nguyễn Vượng (2010) Nghiên cứu đặc điểm giải phẫu bệnh u biểu mô đường niệu của bàng quang.
3. Moch H, Humphrey PA, Ulbright TM, Reuter VE (2016) WHO classification of tumours of the urinary system and male genital organs. Vol 8. International Agency for Research on Cancer (IARC).
4. Raheem SA, Saied AN, Al Shaer R, Mustafa O, Ali AH (2014) The role of CK20, P53 and P63 in differentiation of some urothelial lesions of urinary bladder, immunohistochemical study. Open journal of pathology 4(04): 181.
5. Desai S, Lim SD, Jimenez RE et al (2000) Relationship of cytokeratin 20 and CD44 protein expression with WHO/ISUP grade in pTa and pT1 papillary urothelial neoplasia. Modern Pathology. 13(12): 1315-1323.
6. Mumtaz S, Hashmi AA, Hasan SH, Edhi MM, Khan M (2014) Diagnostic utility of p53 and CK20 immunohistochemical expression grading urothelial malignancies. International archives of medicine 7(1): 36.
7. Şentürk N, Aybek Z, Düzcan E (2010) Ki-67, p53, Bcl-2 and bax expression in urothelial carcinomas of urinary bladder. Turkish Journal of Pathology 26(1): 25-30.
8. Bertz S, Otto W, Denzinger S et al (2014) Combination of CK20 and Ki-67 immunostaining analysis predicts recurrence, progression, and cancer-specific survival in pT1 urothelial bladder cancer. European urology 65(1): 218-226.
Article Sidebar
